Case-matched comparison of long-term results of non-heart beating and heart-beating donor renal transplants

2009 ◽  
Vol 96 (6) ◽  
pp. 685-691 ◽  
Author(s):  
A. D. Barlow ◽  
M. S. Metcalfe ◽  
Y. Johari ◽  
R. Elwell ◽  
P. S. Veitch ◽  
...  
2012 ◽  
Vol 15 (1) ◽  
pp. 4 ◽  
Author(s):  
David M. Holzhey ◽  
William Shi ◽  
A. Rastan ◽  
Michael A. Borger ◽  
Martin H�nsig ◽  
...  

<p><b>Introduction:</b> The goal of this study was to compare the short- and long-term outcomes after aortic valve (AV) surgery carried out via standard sternotomy/partial sternotomy versus transapical transcatheter AV implantation (taTAVI).</p><p><b>Patients and Methods:</b> All 336 patients who underwent taTAVI between 2006 and 2010 were compared with 4533 patients who underwent conventional AV replacement (AVR) operations between 2001 and 2010. Using propensity score matching, we identified and consecutively compared 2 very similar groups of 167 patients each. The focus was on periprocedural complications and long-term survival.</p><p><b>Results:</b> The 30-day mortality rate was 10.8% and 8.4% (<i>P</i> = .56) for the conventional AVR patients and the TAVI patients, respectively. The percentages of postoperative pacemaker implantations (15.0% versus 6.0%, <i>P</i> = .017) and cases of renal failure requiring dialysis (25.7% versus 12.6%, <i>P</i> = .004) were higher in the TAVI group. Kaplan-Meier curves diverged after half a year in favor of conventional surgery. The estimated 3-year survival rates were 53.5% � 5.7% (TAVI) and 66.7% � 0.2% (conventional AVR).</p><p><b>Conclusion:</b> Our study shows that even with all the latest successes in catheter-based AV implantation, the conventional surgical approach is still a very good treatment option with excellent long-term results, even for older, high-risk patients.</p>


1996 ◽  
Vol 9 (s1) ◽  
pp. S81-S83 ◽  
Author(s):  
M. J. Pacholczyk ◽  
B. Łαgiewska ◽  
M. Szostek ◽  
A. Chmura ◽  
M. Morzycka-Michalik ◽  
...  

1999 ◽  
Vol 31 (6) ◽  
pp. 2281-2282 ◽  
Author(s):  
J.C Herrero ◽  
A Andrés ◽  
M Praga ◽  
E Morales ◽  
B Dominguez-Gil ◽  
...  

1996 ◽  
pp. 81-83
Author(s):  
M. J. Pacholczyk ◽  
B. Łągiewska ◽  
M. Szostek ◽  
A. Chmura ◽  
M. Morzycka-Michalik ◽  
...  

1997 ◽  
Vol 29 (1-2) ◽  
pp. 1378-1380 ◽  
Author(s):  
A. Alonso ◽  
J.G. Buitron ◽  
M. Gomez ◽  
A. Fdez Garcia ◽  
C. Fdez Rivera ◽  
...  

2001 ◽  
Vol 33 (1-2) ◽  
pp. 826 ◽  
Author(s):  
M.S Metcalfe ◽  
S.A White ◽  
R.N Saunders ◽  
G.J Murphy ◽  
T Horsburgh ◽  
...  

2007 ◽  
Vol 26 (2) ◽  
pp. S125-S126
Author(s):  
P. Ussetti ◽  
C. Lopez Garcia-Gallo ◽  
D. Gomez de Antonio ◽  
R. Laporta ◽  
C. Carreño ◽  
...  

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Ayse Cetinkaya ◽  
Anna Geier ◽  
Karin Bramlage ◽  
Stefan Hein ◽  
Peter Bramlage ◽  
...  

Abstract Background Mitral valve (MV) surgery has traditionally been performed by conventional sternotomy (CS), but more recently minimally invasive surgery (MIS) has become another treatment option. The aim of this study is to compare short- and long-term results of MV surgery after CS and MIS. Methods This study was a retrospective propensity-matched analysis of MV operations between January 2005 and December 2015. Results Among 1357 patients, 496 underwent CS and 861 MIS. Matching resulted in 422 patients per group. The procedure time was longer with MIS than CS (192 vs. 185 min; p = 0.002) as was cardiopulmonary bypass time (133 vs. 101 min; p < 0.001) and X-clamp time (80 vs. 71 min; p < 0.001). ‘Short-term’ successful valve repair was higher with MIS (96.0% vs. 76.0%, p < 0.001). Length of hospital stay was shorter in MIS than CS patients (10 vs. 11 days; p = 0.001). There was no difference in the overall 30-day mortality rate. Cardiovascular death was lower after MIS (1.2%) compared with CS (3.8%; OR 0.30; 95%CI 0.11–0.84). The difference did not remain significant after adjustment for procedural differences (aOR 0.40; 95%CI 0.13–1.25). Pacemaker was required less often after MIS (3.3%) than CS (11.2%; aOR 0.31; 95%CI 0.16–0.61), and acute renal failure was less common (2.1% vs. 11.9%; aOR 0.22; 95%CI 0.10–0.48). There were no significant differences with respect to rates of stroke, myocardial infarction or repeat MV surgery. The 7-year survival rate was significantly better after MIS (88.5%) than CS (74.8%; aHR 0.44, 95%CI 0.31–0.64). Conclusion This study demonstrates that good results for MV surgery can be obtained with MIS, achieving a high MV repair rate, low peri-procedural morbidity and mortality, and improved long-term survival.


Sign in / Sign up

Export Citation Format

Share Document